Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single cell evaluation of the developing pancreatic tumor microenvironment and its response to chronic jetlag

ABSTRACT: Single cell evaluation of the developing pancreatic tumor microenvironment and its response to chronic jetlag

PROVIDER: PRJNA861852 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR20591108_1.fastq.gz	Fastqsanger.gz
	SRR20591108_2.fastq.gz	Fastqsanger.gz
	SRR20591109_1.fastq.gz	Fastqsanger.gz
	SRR20591109_2.fastq.gz	Fastqsanger.gz
	SRR20591110_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Single cell evaluation of the developing pancreatic tumor microenvironment and its response to chronic jetlag

Project description:Chronic jetlag is a risk factor for cancer development, we subjected mice that develop pancreatic cancer to normal or chronic jetlag conditions and used scRNAseq to evaluate the developing tumor microenvironment

2022-07-27 | GSE209629 | GEO

Chronic pancreatitis vs pancreatic cancer LC-MS

Project description:Age-standardized incidence rates for pancreatic cancer (PC) in men have increased by 25% from 1957 to 2011 in Finland. The average age of diagnosis for PC is 69 years in Nordic males, whereas the average age of diagnosis of chronic pancreatitis (CP) is 40-50 years, but the cases overlap in age. By radiology the evaluation of a pancreatic mass, i.e. the differential diagnosis between CP and PC is often difficult. Preoperative needle biopsies are difficult to obtain and are demanding to interpret. New blood based biomarkers are needed. The accuracy of the only established biomarker for PC, CA 19-9 is rather poor in differentiating between benign and malignant mass of the pancreas. In this study, we have performed mass spectrometry HDMSE analysis of serum samples from patients with chronic pancreatitis and pancreatic cancer. We have quantified 652 proteins and performed detailed statistical analysis such as principal component analysis, orthogonal partial least square discriminant analysis and receiver operating curve analysis.

2017-06-09 | PXD005144 | Pride

Chronic pancreatitis vs pancreatic cancer LC-MS

2018-08-31 | MSV000082883 | MassIVE

Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells

Project description:Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells

| PRJNA422050 | ENA

Acidic microenvironment and transcriptomic genes in pancreatic cancer cells

Project description:Investigating the effect of acidic microenvironment on mRNA transcriptome gene expression in pancreatic cancer cells

2024-10-01 | GSE278328 | GEO

Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors

Project description:<p>Nutrient-deprived conditions in the tumor microenvironment (TME) restrain cancer cell viability due to increased free radicals and reduced energy production. In pancreatic cancer cells, a cytosolic metabolic enzyme, wild-type isocitrate dehydrogenase 1 (wtIDH1), enables the adaptation to these conditions. Under nutrient starvation, wtIDH1 oxidizes isocitrate to generate α-ketoglutarate (αKG) for anaplerosis, and NADPH to support antioxidant defense. In this study, we show that allosteric inhibitors of mutant IDH1 (mIDH1) are potent wtIDH1 inhibitors under conditions present in the TME. We demonstrate that low magnesium levels facilitate allosteric inhibition of wtIDH1, which is lethal to cancer cells when nutrients are limited. Furthermore, the FDA-approved mIDH1 inhibitor ivosidenib (AG-120) dramatically inhibited tumor growth in preclinical models of pancreatic cancer, highlighting this approach as a potential therapeutic strategy against wild-type IDH1 cancers.</p>

2022-04-29 | MTBLS4722 | MetaboLights

Pancreatic Tumor Microenvironment Maintains Tumor Growth through Nucleosides Secretion

Project description:Cancer-associated fibroblasts (CAFs) are one of the most prominent and active components in the pancreatic tumor microenvironment. Our data show that CAFs are critical for PDAC survival upon glutamine deprivation. Specifically, we uncovered a role for nucleosides, which are secreted by CAFs through autophagy in an NUFIP1-depenent manner, increased glucose utilization and promoted growth of PDAC. Moreover, we demonstrate that CAF-derived nucleosides induced glucose consumption under glutamine-deprived conditions and displayed a dependence on MYC. Using an orthotopic mouse model of PDAC, we found that inhibiting nucleoside secretion by targeting NUFIP1 in the stroma reduced tumor weight. This finding highlights a previously unappreciated metabolic network within pancreatic tumors in which diverse nutrients are used to promote growth in an austere tumor microenvironment.

2021-10-19 | GSE185750 | GEO

BRCA Mutation Status Shapes the Microenvironment of Pancreatic Adenocarcinoma

Project description:BRCA Mutation Status Shapes the Microenvironment of Pancreatic Adenocarcinoma

| PRJNA859234 | ENA

BRCA Mutation Status Shapes the Microenvironment of Pancreatic Adenocarcinoma

Project description:BRCA Mutation Status Shapes the Microenvironment of Pancreatic Adenocarcinoma

| PRJNA859233 | ENA

Pancreatic Tumor Microenvironment Maintains Tumor Growth through Nucleosides Secretion

Project description:Pancreatic Tumor Microenvironment Maintains Tumor Growth through Nucleosides Secretion

| PRJNA770663 | ENA